- Home
- PCRX vs UDMY Comparison
PCRX vs UDMY Comparison
Compare PCRX & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- UDMY
- Stock Information
- Founded
- PCRX 2006
- UDMY 2009
- Country
- PCRX United States
- UDMY United States
- Employees
- PCRX N/A
- UDMY N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- UDMY Other Consumer Services
- Sector
- PCRX Health Care
- UDMY Real Estate
- Exchange
- PCRX Nasdaq
- UDMY Nasdaq
- Market Cap
- PCRX 1.2B
- UDMY 1.1B
- IPO Year
- PCRX 2011
- UDMY 2021
- Fundamental
- Price
- PCRX $25.16
- UDMY $9.78
- Analyst Decision
- PCRX Buy
- UDMY Buy
- Analyst Count
- PCRX 9
- UDMY 9
- Target Price
- PCRX $26.22
- UDMY $11.11
- AVG Volume (30 Days)
- PCRX 805.4K
- UDMY 1.3M
- Earning Date
- PCRX 02-27-2025
- UDMY 02-13-2025
- Dividend Yield
- PCRX N/A
- UDMY N/A
- EPS Growth
- PCRX N/A
- UDMY N/A
- EPS
- PCRX N/A
- UDMY N/A
- Revenue
- PCRX $694,957,000.00
- UDMY $786,565,000.00
- Revenue This Year
- PCRX $5.55
- UDMY $3.57
- Revenue Next Year
- PCRX $5.64
- UDMY $6.23
- P/E Ratio
- PCRX N/A
- UDMY N/A
- Revenue Growth
- PCRX 4.40
- UDMY 7.91
- 52 Week Low
- PCRX $11.16
- UDMY $6.67
- 52 Week High
- PCRX $31.67
- UDMY $11.65
- Technical
- Relative Strength Index (RSI)
- PCRX 52.48
- UDMY 71.01
- Support Level
- PCRX $25.41
- UDMY $9.55
- Resistance Level
- PCRX $26.89
- UDMY $10.12
- Average True Range (ATR)
- PCRX 1.18
- UDMY 0.48
- MACD
- PCRX -0.36
- UDMY 0.28
- Stochastic Oscillator
- PCRX 4.35
- UDMY 75.59
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The Company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.